Literature DB >> 12470759

Ocular manifestations of ataxia-telangiectasia.

Arman K Farr1, Benjamin Shalev, Thomas O Crawford, Howard M Lederman, Jerry A Winkelstein, Michael X Repka.   

Abstract

PURPOSE: To report the manifestations of ataxia-telangiectasia (A-T) on the ocular sensory and motor systems.
DESIGN: A prospective observational case series.
METHODS: In a single tertiary care institition, a comprehensive ophthalmologic evaluation was made of patients with A-T as part of a systemic/neurologic evaluation. Sixty-three A-T patients between the ages of 2 and 28 years were examined.
RESULTS: In 58 A-T patients whose visual acuity could be measured, best-corrected visual acuity in the better eye was 20/20 to 20/30 in 39 (67%), 20/40 to 20/50 in 17 (29%), and 20/60 to 20/80 in 2 (4%). The mean geometric visual acuity of the better eye was 20/31. Telangiectatic vessels were seen in the bulbar conjunctiva in 57 of 63 patients (91%) and on the skin of the face of 21 patients (33%). Twenty-four of 63 patients (38%) had strabismus. Esodeviations were the most common, seen in 15 individuals. Apraxia of horizontal gaze was observed in 19 of 63 patients (30%). Hypometric saccades were evident in 48 (76%), pursuit abnormalities in 43 (63%), and nystagmus in 18 (29%). Accommodation was deficient in the 54 patients in whom it was measured. No posterior segment vascular anomalies were detected.
CONCLUSIONS: Visual acuity of 20/50 was present in 96% of the patients we examined. Telangiectatic vessels on the bulbar conjunctiva were seen in nearly every patient, though these are of no functional significance. Ocular motor abnormalities, especially strabismus, are a common finding in A-T. Poor accommodation and abnormal eye movements may lead to reading difficulty reported by patients with A-T.

Entities:  

Mesh:

Year:  2002        PMID: 12470759     DOI: 10.1016/s0002-9394(02)01796-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  13 in total

Review 1.  [Clinical details and genetics of recessive ataxias].

Authors:  C Zühlke; F Kreuz; K Bürk
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

2.  Proton spectroscopy and imaging at 3T in ataxia-telangiectasia.

Authors:  L I Wallis; P D Griffiths; S J Ritchie; C A J Romanowski; G Darwent; I D Wilkinson
Journal:  AJNR Am J Neuroradiol       Date:  2007-01       Impact factor: 3.825

Review 3.  Molecular pathology of ataxia telangiectasia.

Authors:  A M R Taylor; P J Byrd
Journal:  J Clin Pathol       Date:  2005-10       Impact factor: 3.411

4.  Accumulation of Cytoplasmic DNA Due to ATM Deficiency Activates the Microglial Viral Response System with Neurotoxic Consequences.

Authors:  Xuan Song; Fulin Ma; Karl Herrup
Journal:  J Neurosci       Date:  2019-06-12       Impact factor: 6.167

Review 5.  Ataxia-telangiectasia and related diseases.

Authors:  Pierre-Olivier Frappart; Peter J McKinnon
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

Review 6.  An Eye on Movement Disorders.

Authors:  Duncan Wilson; Mark Hallett; Tim Anderson
Journal:  Mov Disord Clin Pract       Date:  2021-08-10

7.  Inhibition of ataxia telangiectasia mutated (ATM) kinase suppresses herpes simplex virus type 1 (HSV-1) keratitis.

Authors:  Oleg Alekseev; Kelly Donovan; Jane Azizkhan-Clifford
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-03       Impact factor: 4.799

Review 8.  Ocular involvement in primary immunodeficiency diseases.

Authors:  Sima Hosseinverdi; Hassan Hashemi; Asghar Aghamohammadi; Hans D Ochs; Nima Rezaei
Journal:  J Clin Immunol       Date:  2013-11-30       Impact factor: 8.542

Review 9.  Ataxia telangiectasia: a review.

Authors:  Cynthia Rothblum-Oviatt; Jennifer Wright; Maureen A Lefton-Greif; Sharon A McGrath-Morrow; Thomas O Crawford; Howard M Lederman
Journal:  Orphanet J Rare Dis       Date:  2016-11-25       Impact factor: 4.123

10.  ATM localization and gene expression in the adult mouse eye.

Authors:  Julia Leemput; Christel Masson; Karine Bigot; Abdelmounaim Errachid; Anouk Dansault; Alexandra Provost; Stéphanie Gadin; Said Aoufouchi; Maurice Menasche; Marc Abitbol
Journal:  Mol Vis       Date:  2009-02-20       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.